BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 2870221)

  • 1. Clinical studies with recombinant-DNA-derived methionyl human growth hormone in growth hormone deficient children.
    Kaplan SL; Underwood LE; August GP; Bell JJ; Blethen SL; Blizzard RM; Brown DR; Foley TP; Hintz RL; Hopwood NJ
    Lancet; 1986 Mar; 1(8483):697-700. PubMed ID: 2870221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case report of growth attenuation during methionyl human growth hormone treatment.
    Okada Y; Taira K; Takano K; Hizuka N
    Endocrinol Jpn; 1987 Aug; 34(4):621-6. PubMed ID: 3678156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of the treatment of growth hormone deficiency with methionine-somatotropin or recombinant somatotropin].
    Dorantes-Alvarez LM
    Bol Med Hosp Infant Mex; 1990 Jun; 47(6):369-71. PubMed ID: 2222818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-year follow-up of growth hormone antibodies in growth hormone deficient children treated with recombinant human growth hormone.
    Massa G; Vanderschueren-Lodeweyckx M; Bouillon R
    Clin Endocrinol (Oxf); 1993 Feb; 38(2):137-42. PubMed ID: 8435894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methionyl human growth hormone and oxandrolone in Turner syndrome: preliminary results of a prospective randomized trial.
    Rosenfeld RG; Hintz RL; Johanson AJ; Brasel JA; Burstein S; Chernausek SD; Clabots T; Frane J; Gotlin RW; Kuntze J
    J Pediatr; 1986 Dec; 109(6):936-43. PubMed ID: 3537249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Turner's syndrome with methionyl human growth hormone for six months.
    Takano K; Hizuka N; Shizume K
    Acta Endocrinol (Copenh); 1986 May; 112(1):130-7. PubMed ID: 3521183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of pituitary dwarfism with methionyl human growth hormone in Japan.
    Takano K; Shizume K; Hizuka N; Okuno A; Umino T; Kobayashi Y; Kusano S; Nakajima H; Irie M; Hibi I
    Endocrinol Jpn; 1986 Oct; 33(5):589-96. PubMed ID: 3830068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of pituitary dwarfism with recombinant human growth hormone. A multicenter study].
    Bierich JR; Ranke MB; Beyer P; Bittner P; Borkenstein H; Brämswig J; Butenandt O; Kollmann F; Stöver B; Schweikert HU
    Dtsch Med Wochenschr; 1986 Mar; 111(13):483-9. PubMed ID: 3514193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial with authentic recombinant somatropin in Sweden and Finland.
    Albertsson-Wikland K
    Acta Paediatr Scand Suppl; 1987; 331():28-34. PubMed ID: 3300153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with somatrem in growth hormone deficiency.
    Vicens-Calvet E; Potau N; Carracosa A; Albisu M; Gusiñer M; Cuatrecasas JM; Strindberg B; Flodh H
    Acta Paediatr Scand Suppl; 1986; 325():33-40. PubMed ID: 3296638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of pituitary dwarfism with authentic recombinant human growth hormone (SM-9500).
    Takano K; Shizume K; Hibi I; Okuno A; Hanyu K; Suwa S; Nakajima H; Kondo T; Kato K; Iwatani N
    Endocrinol Jpn; 1987 Apr; 34(2):291-7. PubMed ID: 3622395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of idiopathic pituitary dwarfism with methionyl human growth hormone.
    Takano K; Shizume K; Hizuka N; Hibi I; Kato K; Kohno H; Kondo T; Ogawa M; Okada Y; Sudo M
    Endocrinol Jpn; 1983 Aug; 30(4):523-7. PubMed ID: 6671456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discordant immune and growth response to pituitary and biosynthetic growth hormone in siblings with isolated growth hormone deficiency type IA.
    Hauffa BP; Illig R; Torresani T; Stolecke H; Phillips JA
    Acta Endocrinol (Copenh); 1989 Nov; 121(5):609-14. PubMed ID: 2588933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterologous humoral immune response in patients treated with human growth hormone from different sources.
    Cardoso AI; Llera AS; Iacono RF; Domené HM; Martínez AS; Heinrich JJ; Peña C; Poskus E
    Acta Endocrinol (Copenh); 1993 Jul; 129(1):20-5. PubMed ID: 8351954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of 1-year growth hormone (GH)-releasing hormone-(1-44) treatment on growth, somatomedin-C, and 24-hour GH secretion in six children with partial GH deficiency.
    Rochiccioli PE; Tauber MT; Coude FX; Arnone M; Morre M; Uboldi F; Barbeau C
    J Clin Endocrinol Metab; 1987 Aug; 65(2):268-74. PubMed ID: 3110202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of pituitary dwarfism with biosynthetic growth hormone.
    Bierich JR
    Acta Paediatr Scand Suppl; 1986; 325():13-8. PubMed ID: 3296634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of biosynthetic human growth hormone immunogenicity in growth hormone deficient children.
    Rougeot C; Marchand P; Dray F; Girard F; Job JC; Pierson M; Ponte C; Rochiccioli P; Rappaport R
    Horm Res; 1991; 35(2):76-81. PubMed ID: 1916657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with Somatonorm.
    Girard F; Gourmelen M
    Acta Paediatr Scand Suppl; 1986; 325():29-32. PubMed ID: 3296637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with authentic recombinant human growth hormone.
    Ranke MB
    Acta Paediatr Scand Suppl; 1986; 325():90-2. PubMed ID: 3296642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current clinical trials with authentic recombinant human growth hormone in Japan.
    Takano K; Shizume K
    Acta Paediatr Scand Suppl; 1986; 325():93-7. PubMed ID: 3296643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.